외과용 봉합사 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 필라멘트별, 용도별, 지역별, 부문별 예측(2024-2030년)

Surgical Sutures Market Size, Share & Trend Analysis Report By Type (Absorbable, Non-Absorbable), By Filament (Monofilament, Multifilament), By Application, By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,251,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,638,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,411,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

외과용 봉합사 시장의 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면 세계 외과용 봉합사 시장 규모는 2024년부터 2030년까지 5.1%의 CAGR을 기록하여 2030년에는 64억 6,000만 달러에 달할 것으로 예측됩니다.

이러한 심장질환은 노령인구의 증가와 심장질환의 증가로 인해 발생합니다. 예를 들어, 세계보건기구(WHO)의 보고에 따르면 심혈관 질환(CVDs)은 전 세계 사망 원인 1위로 매년 약 1,790만 명의 목숨을 앗아가고 있습니다.

라이프스타일의 변화, 의료비 증가, 유리한 상환 시나리오, 의료 인프라 개선을 위한 정부 지원은 시장 성장에 기여하는 중요한 요인입니다. 팬데믹(세계적 대유행) 기간 동안 수익에 일정한 지연이 발생했지만, 시장은 양호한 속도로 회복되고 있습니다. 예측 기간 동안 상당한 성장이 예상됩니다. 의료 시설의 폐쇄와 의료 우선순위의 변화는 시장 수요에 영향을 미쳤습니다. 또한, 제조 활동의 제한과 여행 제한 등 공급망에도 영향을 미쳐 원자재 및 최종 제품 공급에 차질을 빚고 있습니다.

시장의 주요 업체들은 시장에서의 입지를 강화하기 위해 첨단 수술용 봉합사 개발에 주력하고 있습니다. 예를 들어, 제네시스 메드텍(Genesis MedTech)은 2023년 9월 중국 NMPA로부터 항균 보호 기능을 갖춘 흡수성 봉합사 출시를 승인받았습니다. 이에 따라 시장 리더들의 연구개발 활동에 대한 투자가 증가하고 있으며, 향후 시장 확대가 기대됩니다.

외과용 봉합사 시장 보고서 하이라이트

• 유형별로는 흡수성 부문이 2023년 가장 높은 시장 점유율을 차지하며 시장을 장악했습니다.
• 필라멘트별로는 멀티 필라멘트가 유연성, 유연성, 높은 인장 강도 등의 장점으로 인해 2023년 가장 높은 매출 점유율을 차지했습니다.
• 용도별로는 심장 수술 분야가 2023년 시장을 장악했습니다. 이는 심장 질환의 높은 발병률, 지원적인 상환 시나리오, 이 분야의 충분한 전문가 존재, 진단의 기술 발전으로 인한 것입니다.
• 북미 지역이 2023년 가장 높은 매출 점유율을 차지한 것은 심장병 발병률 증가, 시장 내 현지 및 주요 기업의 존재, 다른 지역에 비해 높은 봉합사 비용, 지원적인 상환 시나리오, 의료 인프라 개발에 따른 정부 프로그램 때문인 것으로 분석됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 외과용 봉합사 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상부 시장 전망
  • 관련/보조적인 시장 전망.
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 외과용 봉합사 시장 분석 툴
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 외과용 봉합사 시장 : 유형별 추정·동향 분석

• 정의와 범위
• 유형 시장 점유율, 2018년 및 2030년
• 부문 대시보드
• 유형별 세계의 외과용 봉합사 시장 전망
• 시장 규모, 예측 및 동향 분석, 2018년부터 2030년까지

제5장 외과용 봉합사 시장 : 필라멘트별 추정·동향 분석

• 정의와 범위
• 필라멘트 시장 점유율, 2018년과 2030년
• 부문 대시보드
• 필라멘트별 세계의 외과용 봉합사 시장 전망
• 시장 규모, 예측 및 동향 분석, 2018년부터 2030년까지

제6장 외과용 봉합사 시장 : 용도별 추정·동향 분석

• 정의와 범위
• 용도 시장 점유율, 2018년 및 2030년
• 부문 대시보드
• 용도별 세계의 외과용 봉합사 시장 전망
• 시장 규모, 예측 및 동향 분석, 2018년부터 2030년까지

제7장 외과용 봉합사 시장 : 지역 추정·동향 분석

• 지역 시장 점유율 분석, 2023년 및 2030년
• 지역 시장 대시보드
• 세계의 지역 시장 현황
• 시장 규모와 예측 동향 분석, 2018년에서 2030년
• 북미
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 상황

• 주요 시장 진출 기업에 의한 최근의 동향과 영향 분석
• 회사/경쟁 분류
  • 이노베이터
• 벤더 상황
  • List of key distributors and channel partners
  • Key customers
  • Key company market share analysis, 2023
  • Covidien
  • ETHICON US, LLC(Johnson &Johnson Services, Inc.)
  • B. BRAUN MESUNGEN AG
  • SMITH &NEPHEW
  • Integra Life Sciences
  • INTERNACIONAL FARMACEUTICA
  • SUTURES INDIA PVT. LTD
  • CONMED CORPORATION

ksm

영문 목차

영문목차

Surgical Sutures Market Growth & Trends:

The global surgical sutures market size is expected to reach USD 6.46 billion by 2030, registering a CAGR of 5.1% from 2024 to 2030, based on a new report by Grand View Research, Inc., Rise in surgical procedures due to an increasing number of cardiac diseases is predicted to foster the market growth. These cardiac diseases occur due to the increasing geriatric population and rising number of heart ailments. For instance, according to a WHO report, cardiovascular diseases (CVDs) are the leading cause of death globally; it takes around 17.9 million lives each year.

Lifestyle changes, growing healthcare expenditure, favorable reimbursement scenarios, and government support to improve the healthcare infrastructure are significant factors contributing to the growth of the market. Although the market may have experienced a certain lag in revenue during the pandemic, it is recovering at a decent pace. It is expected to grow considerably during the forecast period. The lockdowns and changes in healthcare priorities have affected the market's demand. The restrictions also affected the supply chain with limited manufacturing activities and travel restrictions, which disrupted the supply of raw materials and the final product.

Key market players are focusing on developing advanced surgical sutures to enhance their market position. For instance, in September 2023, Genesis MedTech obtained approval from China's NMPA for the market release of its absorbable sutures with antibacterial protection, designed to enhance healing and reduce infection risk. This has led to increasing investment in R&D activities by market leaders, further expected to benefit the market in the future.

Surgical Sutures Market Report Highlights:

• Based on type, the absorbable segment dominated the market with the highest market share in 2023 owing to higher adoption due to its ability to degrade naturally
• Based on filament, the multifilament segment held the highest revenue share in 2023 owing to the advantages it offers such as pliability, flexibility, and high tensile strength
• Based on application, the cardiac surgery segment dominated the market in 2023 owing to the high incidence of cardiac diseases, supportive reimbursement scenario, presence of sufficient experts in the field, and technological advancements in diagnostics
• North America region held the highest revenue share in 2023 due to increasing incidence of cardiac diseases, presence of local as well as key players in the market, high cost of sutures compared to other regions, supportive reimbursement scenario, and government programs along with developed healthcare infrastructure

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type
  • 1.1.2. Filament
  • 1.1.3. Application
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Filament outlook
  • 2.2.3. Application outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Surgical Suture Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rise in surgical procedure
    • 3.2.1.2. Technological advancement
    • 3.2.1.3. Improving healthcare infrastructure in emerging economies
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Strong competition from other wound closure technologies
• 3.3. Surgical Sutures Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Surgical Sutures Market: Type Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Absorbable Type
  • 4.1.2. Non-absorable Type
• 4.2. Type Market Share, 2018 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Surgical Sutures Market by Type Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. Absorbable Type
    • 4.5.1.1. Absorbale type market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Non-absorbable Type
    • 4.5.2.1. Non-absorable type market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Surgical Sutures Market: Filament Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Monofilament
  • 5.1.2. Multifilament
• 5.2. Filament Market Share, 2018 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Surgical Sutures Market by Filament Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Monofilament
    • 5.5.1.1. Monofilament market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Multifilament
    • 5.5.2.1. Multifilament market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Surgical Sutures Market: Application Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Ophthalmic Surgery
  • 6.1.2. Cardiovascular Surgery
  • 6.1.3. Orthopedic Surgery
  • 6.1.4. Neurological Surgery
  • 6.1.5. Others
• 6.2. Application Market Share, 2018 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Surgical Sutures Market by Application Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Ophthalmic Surgery
    • 6.5.1.1. Ophthalmic Surgery market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.2. Cardiovascular Surgery
    • 6.5.2.1. Cardiovascular Surgery market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.3. Orthopedic Surgery
    • 6.5.3.1. Orthopedic Surgery market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.4. Neurological Surgery
    • 6.5.4.1. Neurological Surgery market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.5. Others
    • 6.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Surgical Sutures Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Competitive scenario
    • 7.5.1.3. Regulatory framework
    • 7.5.1.4. Reimbursement scenario
    • 7.5.1.5. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. Canada market estimates and forecast, 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Competitive scenario
    • 7.6.1.3. Regulatory framework
    • 7.6.1.4. Reimbursement scenario
    • 7.6.1.5. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. France market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Regulatory framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Regulatory framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Competitive scenario
    • 7.6.7.3. Regulatory framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Competitive scenario
    • 7.6.8.3. Regulatory framework
    • 7.6.8.4. Reimbursement scenario
    • 7.6.8.5. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement scenario
    • 7.7.1.5. Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. China market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. India market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Competitive scenario
    • 7.7.6.3. Regulatory framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement scenario
    • 7.8.1.5. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.2. Mexico
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive scenario
    • 7.8.3.3. Regulatory framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive scenario
    • 7.9.1.3. Regulatory framework
    • 7.9.1.4. Reimbursement scenario
    • 7.9.1.5. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive scenario
    • 7.9.2.3. Regulatory framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive scenario
    • 7.9.3.3. Regulatory framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Competitive scenario
    • 7.9.4.3. Regulatory framework
    • 7.9.4.4. Reimbursement scenario
    • 7.9.4.5. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2023
  • 8.3.4. Covidien
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. ETHICON US, LLC (Johnson & Johnson Services, Inc.)
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. B. BRAUN MESUNGEN AG
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. SMITH & NEPHEW
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Integra Life Sciences
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. INTERNACIONAL FARMACEUTICA
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. SUTURES INDIA PVT. LTD
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. CONMED CORPORATION
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives

관련자료